Cardiovascular, Kidney Failure, and All-Cause Mortality Events in Patients with FSGS in a US Real-World Database.

Autor: Velez JCQ; Department of Nephrology, Ochsner Health, New Orleans, Louisiana.; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia., Thakker KM; Notting Hill Consulting LLC, Celebration, Florida., Bensink ME; Travere Therapeutics, Inc., San Diego, California., Lerma EV; University of Illinois Chicago/Advocate Christ Medical Center, Oak Lawn, Illinois., Lieblich R; VJA Consulting, Walnut Creek, California., Bunke CM; CM Bunke Consulting, Mt. Pleasant, South Carolina., Gong W; Travere Therapeutics, Inc., San Diego, California., Wang K; Travere Therapeutics, Inc., San Diego, California., Rava AR; Genesis Research Group, Hoboken, New Jersey., Amari DT; Genesis Research Group, Hoboken, New Jersey., Oliveri D; Genesis Research Group, Hoboken, New Jersey., Murphy MV; Genesis Research Group, Hoboken, New Jersey., Cork DMW; Genesis Research Group, Newcastle upon Tyne, United Kingdom.
Jazyk: angličtina
Zdroj: Kidney360 [Kidney360] 2024 Aug 01; Vol. 5 (8), pp. 1145-1153. Date of Electronic Publication: 2024 May 15.
DOI: 10.34067/KID.0000000000000469
Databáze: MEDLINE